Ninety One’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.2M Sell
142,414
-10,509
-7% -$2.45M 1.96% 6
2026
Q1
$37.3M Buy
152,923
+16,154
+12% +$3.76M 1.6% 6
2025
Q4
$28.3M Buy
136,769
+29,594
+28% +$5.85M 1.22% 6
2025
Q3
$19.7M Buy
107,175
+7,484
+8% +$1.28M 0.89% 14
2025
Q2
$15.2M Buy
99,691
+31,524
+46% +$4.85M 2.5% 12
2025
Q1
$11.3M Buy
68,167
+5,157
+8% +$807K 2.1% 13
2024
Q4
$9.11M Sell
63,010
-5,078
-7% -$787K 2.01% 13
2024
Q3
$11M Buy
68,088
+8,499
+14% +$1.35M 2.41% 12
2024
Q2
$8.71M Sell
59,589
-2,815
-5% -$419K 1.35% 25
2024
Q1
$9.89M Sell
62,404
-3,473
-5% -$553K 1.42% 25
2023
Q4
$10.3M Buy
65,877
+11,495
+21% +$1.76M 1.57% 23
2023
Q3
$8.48M Buy
54,382
+5,266
+11% +$869K 1.64% 23
2023
Q2
$8.11M Buy
49,116
+4,025
+9% +$650K 2.01% 16
2023
Q1
$6.96M Sell
45,091
-1,469
-3% -$237K 1.77% 16
2022
Q4
$8.23M Sell
46,560
-8,386
-15% -$1.45M 2.67% 9
2022
Q3
$9.01M Buy
54,946
+15,852
+41% +$2.68M 3.57% 5
2022
Q2
$6.93M Sell
39,094
-7,630
-16% -$1.36M 2.45% 9
2022
Q1
$8.31M Sell
46,724
-1,572
-3% -$267K 2.32% 8
2021
Q4
$8.28M Buy
48,296
+27,836
+136% +$4.56M 2.42% 9
2021
Q3
$3.33M Buy
20,460
+718
+4% +$122K 1.3% 19
2021
Q2
$3.24M Buy
19,742
+11,587
+142% +$1.92M 1.19% 18
2021
Q1
$1.34M Hold
8,155
0.51% 58
2020
Q4
$1.28M Hold
8,155
0.5% 52
2020
Q3
$1.21M Buy
8,155
+99
+1% +$14.6K 0.61% 45
2020
Q2
$1.13M Hold
8,056
0.54% 40
2020
Q1
$1.06M Sell
8,056
-136
-2% -$19.3K 0.52% 42
2019
Q4
$1.06M Hold
8,192
0.6% 61
2019
Q3
$1.06M Hold
8,192
0.6% 61
2019
Q2
$1.14M Sell
8,192
-175,700
-96% -$24.3M 0.64% 58
2019
Q1
$25.6M Sell
183,892
-12,560
-6% -$1.68M 13.52% 2
2018
Q4
$25.2M Sell
196,452
-43,091
-18% -$6.01M 14.81% 2
2018
Q3
$33.1M Sell
239,543
-29,640
-11% -$3.94M 5.42% 3
2018
Q2
$33M Buy
269,183
+62,060
+30% +$7.74M 4.47% 3
2018
Q1
$26.4M Sell
207,123
-730
-0.4% -$98.7K 12.36% 3
2017
Q4
$29.3M Buy
207,853
+4,100
+2% +$571K 14.61% 1
2017
Q3
$26.4M Buy
203,753
+518
+0.3% +$68.7K 13.92% 2
2017
Q2
$26.9M Buy
203,235
+5,994
+3% +$765K 14.92% 2
2017
Q1
$24.6M Buy
197,241
+355
+0.2% +$42.4K 16% 2
2016
Q4
$22.7M Sell
196,886
-5,310
-3% -$613K 15.46% 1
2016
Q3
$23.9M Sell
202,196
-8,328
-4% -$1.01M 15.18% 2
2016
Q2
$25.2M Buy
210,524
+17,582
+9% +$2M 21.72% 2
2016
Q1
$20.9M Buy
192,942
+8,840
+5% +$915K 19.82% 2
2015
Q4
$19M Buy
184,102
+1,624
+0.9% +$163K 16.79% 2
2015
Q3
$17M Hold
182,478
15.53% 4
2015
Q2
$17.9M Buy
+182,478
New +$18.3M 16.42% 4

Other funds holding JNJ

Ninety One's JNJ Position: Q2 2026 in Review

Ninety One reduced its Johnson & Johnson (JNJ) stake by 6.9% in Q2 2026, selling an estimated $2.45M and leaving 142,414 shares worth $36.2M. The position accounts for 1.96% of the portfolio, ranked #6.

Ninety One first reported a position in JNJ in Q2 2015 and has held it in 45 quarters since. The position peaked at $37.3M in Q1 2026. 2,347 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ninety One held 142,414 shares of Johnson & Johnson worth $36.2M as of Q2 2026.
  • Ninety One sold 10,509 Johnson & Johnson shares in Q2 2026, an estimated $2.45M.
  • Johnson & Johnson made up 1.96% of Ninety One's portfolio in Q2 2026, its #6 holding.
  • Ninety One first reported a position in Johnson & Johnson in Q2 2015 and has held it in 45 quarters since.
  • Ninety One's Johnson & Johnson position peaked at $37.3M in Q1 2026.
  • 2,347 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ninety One's 13F filing for Q2 2026, filed 16 Jul 2026.